PharmX Technologies Limited (ASX:PHX)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
Jul 29, 2026, 9:59 AM AEST
PharmX Technologies Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 66 | 56 | 23 | 22 | 20 | 52 | |
Market Cap Growth | 11.30% | 144.74% | 2.90% | 8.94% | -60.92% | 199.92% |
Enterprise Value | 63 | 51 | 11 | 17 | 14 | 45 |
Last Close Price | 0.10 | 0.09 | 0.04 | 0.03 | 0.03 | 0.07 |
PE Ratio | - | - | - | - | 80.52 | 47.59 |
Forward PE | - | 21.25 | 21.25 | 21.25 | 21.25 | 21.75 |
PS Ratio | 8.62 | 7.39 | 2.81 | 3.61 | 3.77 | 4.37 |
PB Ratio | 4.23 | 3.50 | 1.42 | 1.00 | 0.87 | 2.26 |
P/TBV Ratio | 17.29 | 13.45 | 7.48 | 2.50 | 8.19 | 14.24 |
P/FCF Ratio | 67.43 | - | 7.13 | 2.04 | 6.37 | 18.14 |
P/OCF Ratio | 65.42 | - | 7.10 | 2.02 | 6.18 | 16.42 |
EV/Sales Ratio | 8.30 | 6.82 | 1.31 | 2.78 | 2.65 | 3.78 |
EV/EBITDA Ratio | - | 129.72 | 19.99 | - | 21.02 | 26.90 |
EV/EBIT Ratio | - | 466.97 | 43.42 | - | 112.40 | 36.72 |
EV/FCF Ratio | 64.88 | - | 3.32 | 1.57 | 4.48 | 15.67 |
Debt / Equity Ratio | 0.05 | 0.06 | 0.02 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | 1.73 | 0.38 | - | 0.32 | 0.15 |
Debt / FCF Ratio | 0.74 | - | 0.08 | 0.00 | 0.10 | 0.11 |
Net Debt / Equity Ratio | -0.16 | -0.21 | -0.81 | -0.57 | -0.23 | -0.27 |
Net Debt / EBITDA Ratio | 5.89 | -8.28 | -24.33 | 58.33 | -8.00 | -3.69 |
Net Debt / FCF Ratio | -2.55 | 0.40 | -4.04 | -1.18 | -1.71 | -2.15 |
Asset Turnover | 0.43 | 0.31 | 0.24 | 0.18 | 0.17 | 0.47 |
Inventory Turnover | - | - | - | - | 85.40 | 173.43 |
Quick Ratio | 3.56 | 3.27 | 1.36 | 1.25 | 1.64 | 1.39 |
Current Ratio | 3.68 | 3.33 | 1.37 | 1.84 | 1.68 | 1.63 |
Return on Equity (ROE) | -5.86% | -1.65% | 0.50% | -3.89% | -0.57% | 5.97% |
Return on Assets (ROA) | -2.47% | 0.28% | 0.46% | -1.23% | 0.26% | 3.02% |
Return on Invested Capital (ROIC) | -5.42% | -4.67% | 1.84% | -4.89% | -0.79% | 6.89% |
Return on Capital Employed (ROCE) | -4.30% | 0.60% | 1.40% | -2.70% | 0.50% | 4.90% |
Earnings Yield | -1.41% | -0.47% | -7.78% | -4.75% | 1.24% | 2.10% |
FCF Yield | 1.48% | -14.66% | 14.02% | 49.13% | 15.70% | 5.51% |
Payout Ratio | - | - | - | - | - | 82.13% |
Buyback Yield / Dilution | 1.38% | -0.06% | -0.17% | 0.56% | -9.81% | -57.55% |
Total Shareholder Return | 1.38% | -0.06% | -0.17% | 0.56% | -9.81% | -57.55% |